Global Drug based on CAR T-Cell Market Growth (Status and Outlook) 2022-2028

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.

The global market for Drug based on CAR T-Cell is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Drug based on CAR T-Cell players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J and JW Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Drug based on CAR T-Cell market, with both quantitative and qualitative data, to help readers understand how the Drug based on CAR T-Cell market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Drug based on CAR T-Cell market and forecasts the market size by Type (CD19-targeted and BCMA-targeted,), by Application (Lymphoma and Multiple Myeloma.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
    CD19-targeted
    BCMA-targeted

Segmentation by application
    Lymphoma
    Multiple Myeloma

Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Major companies covered
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    CARsgen Therapeutics (Pipeline)
    CARsgen Therapeutics
    Autolus Therapeutics
    Sorrento Therapeutics
    Mustang Bio
    Bluebird Bio
    Cellectis
    Allogene Therapeutics
    Celyad

Chapter Introduction
Chapter 1: Scope of Drug based on CAR T-Cell, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug based on CAR T-Cell market size and CAGR, Drug based on CAR T-Cell market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug based on CAR T-Cell revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug based on CAR T-Cell revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug based on CAR T-Cell market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics and Autolus Therapeutics, etc.
Chapter 14: Research Findings and Conclusion

List of Tables
    Table 1. Drug based on CAR T-Cell Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of CD19-targeted
    Table 3. Major Players of BCMA-targeted
    Table 4. Drug based on CAR T-Cell Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
    Table 7. Drug based on CAR T-Cell Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
    Table 10. Global Drug based on CAR T-Cell Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Drug based on CAR T-Cell Revenue Market Share by Player (2020-2022)
    Table 12. Drug based on CAR T-Cell Key Players Head office and Products Offered
    Table 13. Drug based on CAR T-Cell Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Drug based on CAR T-Cell Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Drug based on CAR T-Cell Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Drug based on CAR T-Cell Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Drug based on CAR T-Cell Market Size Market Share by Country (2017-2022)
    Table 20. Americas Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
    Table 22. Americas Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
    Table 24. APAC Drug based on CAR T-Cell Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Drug based on CAR T-Cell Market Size Market Share by Region (2017-2022)
    Table 26. APAC Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
    Table 28. APAC Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
    Table 30. Europe Drug based on CAR T-Cell Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Drug based on CAR T-Cell Market Size Market Share by Country (2017-2022)
    Table 32. Europe Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
    Table 34. Europe Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Drug based on CAR T-Cell Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Drug based on CAR T-Cell
    Table 43. Key Market Challenges & Risks of Drug based on CAR T-Cell
    Table 44. Key Industry Trends of Drug based on CAR T-Cell
    Table 45. Global Drug based on CAR T-Cell Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Drug based on CAR T-Cell Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Drug based on CAR T-Cell Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Novartis Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 52. Novartis Drug based on CAR T-Cell Product Offered
    Table 53. Novartis Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Novartis Main Business
    Table 55. Novartis Latest Developments
    Table 56. Gilead Sciences Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 57. Gilead Sciences Drug based on CAR T-Cell Product Offered
    Table 58. Gilead Sciences Main Business
    Table 59. Gilead Sciences Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Gilead Sciences Latest Developments
    Table 61. Bristol-Myers Squibb Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 62. Bristol-Myers Squibb Drug based on CAR T-Cell Product Offered
    Table 63. Bristol-Myers Squibb Main Business
    Table 64. Bristol-Myers Squibb Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Bristol-Myers Squibb Latest Developments
    Table 66. J & J Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 67. J & J Drug based on CAR T-Cell Product Offered
    Table 68. J & J Main Business
    Table 69. J & J Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. J & J Latest Developments
    Table 71. JW Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 72. JW Therapeutics Drug based on CAR T-Cell Product Offered
    Table 73. JW Therapeutics Main Business
    Table 74. JW Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. JW Therapeutics Latest Developments
    Table 76. FOSUNKite Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 77. FOSUNKite Drug based on CAR T-Cell Product Offered
    Table 78. FOSUNKite Main Business
    Table 79. FOSUNKite Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. FOSUNKite Latest Developments
    Table 81. CARsgen Therapeutics (Pipeline) Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 82. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Offered
    Table 83. CARsgen Therapeutics (Pipeline) Main Business
    Table 84. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. CARsgen Therapeutics (Pipeline) Latest Developments
    Table 86. CARsgen Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 87. CARsgen Therapeutics Drug based on CAR T-Cell Product Offered
    Table 88. CARsgen Therapeutics Main Business
    Table 89. CARsgen Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. CARsgen Therapeutics Latest Developments
    Table 91. Autolus Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 92. Autolus Therapeutics Drug based on CAR T-Cell Product Offered
    Table 93. Autolus Therapeutics Main Business
    Table 94. Autolus Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Autolus Therapeutics Latest Developments
    Table 96. Sorrento Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 97. Sorrento Therapeutics Drug based on CAR T-Cell Product Offered
    Table 98. Sorrento Therapeutics Main Business
    Table 99. Sorrento Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Sorrento Therapeutics Latest Developments
    Table 101. Mustang Bio Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 102. Mustang Bio Drug based on CAR T-Cell Product Offered
    Table 103. Mustang Bio Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Mustang Bio Main Business
    Table 105. Mustang Bio Latest Developments
    Table 106. Bluebird Bio Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 107. Bluebird Bio Drug based on CAR T-Cell Product Offered
    Table 108. Bluebird Bio Main Business
    Table 109. Bluebird Bio Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Bluebird Bio Latest Developments
    Table 111. Cellectis Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 112. Cellectis Drug based on CAR T-Cell Product Offered
    Table 113. Cellectis Main Business
    Table 114. Cellectis Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. Cellectis Latest Developments
    Table 116. Allogene Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 117. Allogene Therapeutics Drug based on CAR T-Cell Product Offered
    Table 118. Allogene Therapeutics Main Business
    Table 119. Allogene Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. Allogene Therapeutics Latest Developments
    Table 121. Celyad Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
    Table 122. Celyad Drug based on CAR T-Cell Product Offered
    Table 123. Celyad Main Business
    Table 124. Celyad Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. Celyad Latest Developments
List of Figures
List of Figures
    Figure 1. Drug based on CAR T-Cell Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Drug based on CAR T-Cell Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Drug based on CAR T-Cell Market Size Market Share by Type in 2021
    Figure 7. Drug based on CAR T-Cell in Lymphoma
    Figure 8. Global Drug based on CAR T-Cell Market: Lymphoma (2017-2022) & ($ Millions)
    Figure 9. Drug based on CAR T-Cell in Multiple Myeloma
    Figure 10. Global Drug based on CAR T-Cell Market: Multiple Myeloma (2017-2022) & ($ Millions)
    Figure 11. Global Drug based on CAR T-Cell Market Size Market Share by Application in 2021
    Figure 12. Global Drug based on CAR T-Cell Revenue Market Share by Player in 2021
    Figure 13. Global Drug based on CAR T-Cell Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Drug based on CAR T-Cell Value Market Share by Country in 2021
    Figure 19. Americas Drug based on CAR T-Cell Consumption Market Share by Type in 2021
    Figure 20. Americas Drug based on CAR T-Cell Market Size Market Share by Application in 2021
    Figure 21. United States Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Drug based on CAR T-Cell Market Size Market Share by Region in 2021
    Figure 26. APAC Drug based on CAR T-Cell Market Size Market Share by Application in 2021
    Figure 27. China Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Drug based on CAR T-Cell Market Size Market Share by Country in 2021
    Figure 34. Europe Drug based on CAR T-Cell Market Size Market Share by Type in 2021
    Figure 35. Europe Drug based on CAR T-Cell Market Size Market Share by Application in 2021
    Figure 36. Germany Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Application in 2021
    Figure 44. Egypt Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 53. United States Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 57. China Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 61. India Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 64. France Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 65. UK Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)

This latest report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug based on CAR T-Cell market, with both quantitative and qualitative data, to help readers understand how the Drug based on CAR T-Cell market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug based on CAR T-Cell market and forecasts the market size by Type (CD19-targeted and BCMA-targeted,), by Application (Lymphoma and Multiple Myeloma.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
    CD19-targeted
    BCMA-targeted
Segmentation by application
    Lymphoma
    Multiple Myeloma
Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries
Major companies covered
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    CARsgen Therapeutics (Pipeline)
    CARsgen Therapeutics
    Autolus Therapeutics
    Sorrento Therapeutics
    Mustang Bio
    Bluebird Bio
    Cellectis
    Allogene Therapeutics
    Celyad
Chapter Introduction
Chapter 1: Scope of Drug based on CAR T-Cell, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug based on CAR T-Cell market size and CAGR, Drug based on CAR T-Cell market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug based on CAR T-Cell revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug based on CAR T-Cell revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug based on CAR T-Cell market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics and Autolus Therapeutics, etc.
Chapter 14: Research Findings and Conclusion

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape